Case Control Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Jan 14, 2021; 27(2): 162-175
Published online Jan 14, 2021. doi: 10.3748/wjg.v27.i2.162
Figure 3
Figure 3 Measurement of the serum 10-7G value and fucosylated prohaptoglobin amount in patients with inflammatory bowel disease. A: Serum 10-7G value of healthy volunteers and patients with ulcerative colitis, Crohn’s disease, or acute enteritis. Values are shown in relative units; B and C: Coefficients of correlation (B) between the 10-7G value and Fuc-pHpt amount and (C) between the 10-7G value and AAL-mHpt level. HV: Healthy volunteer; UC: Ulcerative colitis; CD: Crohn’s disease; AE: Acute enteritis.

  • Citation: Motooka K, Morishita K, Ito N, Shinzaki S, Tashiro T, Nojima S, Shimizu K, Date M, Sakata N, Yamada M, Takamatsu S, Kamada Y, Iijima H, Mizushima T, Morii E, Takehara T, Miyoshi E. Detection of fucosylated haptoglobin using the 10-7G antibody as a biomarker for evaluating endoscopic remission in ulcerative colitis. World J Gastroenterol 2021; 27(2): 162-175
  • URL: https://www.wjgnet.com/1007-9327/full/v27/i2/162.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v27.i2.162